Perioperative PD-1 Inhibition Expands Treatment Opportunities for Select Patients With CSCC

Announcements
Vishal Patel

As the role of immunotherapies extends to earlier treatment lines in the nonmelanoma skin cancer treatment armamentarium, increased attention to patient characteristics and disease factors is crucial to ensure all patients receive tolerable therapies at the optimal time during the course of their disease, according to Vishal Patel, MD, FAAD, FACMS.

Read the OncLive® article.

Latest News

Christina Lisi
When the Going Gets Tough, the Tough Build Community
Christina Lisi’s personal foundation is built upon community. After receiving a breast cancer diagnosis, she reached out to friends and family, who rallied around her as she sussed out care teams and treatment options. And when she chose GW’s Breast Center and Cancer Center as her cancer journey…
Badjo Kouadio, GW Cancer Center Radiation Therapist
Five Questions with Badjo Kouadio, RT
Radiation therapist Badjo Kouadio won the lottery — a few times. The first time was when she entered the Diversity Visa lottery (also known as the Green Card lottery) and came to the United States. The second time was when she became a radiation technologist and began a defining career that…
Ashok Kumar, MD
Prashanth Ashok Kumar, MD, Joins the GW Cancer Center as Hematologist-Oncologist Specializing in Thoracic Cancers and Primary CNS Tumors
The GW Cancer Center is proud to announce the addition of Prashanth Ashok Kumar, MD, to its hematologist-oncologist team. Ashok Kumar, who specializes in thoracic cancers and primary CNS tumors, further strengthens the center's commitment to providing top-tier, patient-centered cancer care.